CompletedPhase 1psilocybin

Consciousness, Psilocybin, and Well-Being

Sponsored by University of Wisconsin, Madison

NCT ID
NCT05592379
Target Enrollment
6 participants
Start Date
2023-11-07
Est. Completion
2025-02-19

About This Study

This study is being done to identify a dosing strategy that will allow IV psilocybin to be administered to sleeping participants without awakening them.

Conditions Studied

HealthyPsychedelic ExperiencesSleep

Interventions

  • •Psilocybin
  • •Clonidine
  • •Saline

Eligibility

Age:18 Years - 45 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Medically healthy
* English-speaking
* Live within 150 miles of Madison, WI for duration of study

Exclusion Criteria:

* Current use of medications that may interact with psilocybin
* Current sleep disorder, including (but not limited to) insomnia, sleep apnea, restless legs syndrome, and/or narcolepsy
* Females with positive urine pregnancy at any time point during screening or study participation
* Current cardiac valve disease

Study Locations (1)

University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Consciousness, Psilocybin, and Well-Being | Huxley